Events

This virtual workshop will review the basic concepts behind Learning Health Systems including the learning cycle, infrastructure, and learning communities. Participants will engage in a collaborative activity to design a learning cycle.

Commercial flow cytometers are highly utilized clinical and research instruments that make thousands of single-cell measurements per second. However inherent instrument variability coupled with changes in operating conditions or procedures hinder day-to-day and lab-to-lab comparability of data. Moreover, the challenges of developing physically-informed mathematical analyses prevent cytometers from having well-characterized uncertainties, thereby limiting their ability to detect rare events (a task nonetheless suited to their throughput). To address these issues, we have developed an optofluidic system that interlaces advanced fabrication techniques and novel signals analysis to dramatically improve understanding of measurement variability and rare event detection.

Chase Weidmann, Department of Biological Chemistry, Sethu Pitchiaya, Department of Urology

University of Vermont- This biennial invitational event draws top researchers in the field and their trainees, from around the world. The purpose of the meeting is to discuss recent research, explore opportunities for new collaborations, and identify the most important needs and priorities for future programs in stem cell, cell therapy, and bioengineering approaches to explore lung biology and/or prevent and treat lung diseases.

The 99th General Session of the IADR, the 50th Meeting of the AADR and the 45th Meeting of the CADR will take place July 21-24, 2021 as a virtual experience. The 2021 IADR/AADR/CADR General Session will be a virtual meeting, offering opportunities to attend, present, engage and network from around the world. Virtual attendees will be able to attend sessions presented from around the world and interact with presenters in real time or on demand.

Regenerative medicine and tissue engineering apply the principles of cell transplantation, material sciences, and bioengineering to construct biological substitutes that may restore and maintain normal function in diseased and injured tissues. Applications of these new technologies that may offer novel diagnostics and therapies for patients with tissue injury and organ disease will be described. Recent advances that have occurred in regenerative medicine will be reviewed.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 80+ dedicated presentations by the leading publicly traded and privately held companies in the space.

Meet the industry forerunners at BSC's inaugural Advancing Gene Therapy 2021 to gain insights into their strategies and program development. The Summit will highlight the challenging field of gene therapeutic approaches. Advances in development and manufacturing will be presented, as well as quality control methods and regulatory aspects: The focus is on the path to safe and beneficial advanced therapies for the patient.